Indian markets showed resilience, recovering some Budget-day losses. Several key companies are under the spotlight today. Bajaj Finance and Adani Enterprises will announce their third-quarter results. RIL faces a legal challenge from the government. Eicher Motors reported strong January sales. Lupin launched a generic cancer drug in the US. Investors watch these developments closely.
SIP or lump-sum? How to invest smart after the India–US trade deal
Investors face a choice between systematic investment plans and lumpsum investments. Financial planners suggest the decision hinges on market valuations, momentum, and individual risk tolerance.